New Delhi, Feb. 25 -- The alternative investment arm of Motilal Oswal Financial Services Ltd has acquired a majority stake in export-focused bulk drug maker Megafine Pharma Ltd for Rs.460 crore, betting on its growth as global companies look to diversify supply chains out of China.

Motilal Oswal Alternates (MO Alts) is looking at further inorganic opportunities to grow the platform, Rohit Mantri, managing director and co-head of private equity at MO Alts, told Mint in an interview. "This is our first sole control investment as MO Alts, and we would focus on further strengthening R&D (research and development) and manufacturing capabilities, and creating a platform for further inorganic opportunities."

"We'd look at inorganic opportuniti...